It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that…
Super UserJanuary 18, 2022
-- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in South Korea GAITHERSBURG, Md., Jan.…
Super UserJanuary 18, 2022
January 10, 2022 by Ronald Piervincenzi The COVID-19 pandemic made the last year both an extraordinary and challenging time to…
Super UserJanuary 12, 2022
Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments have moved to a decentralized…
Super UserJanuary 12, 2022
ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in partnership with AbbVie, is expected…
Super UserJanuary 10, 2022
Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center.…
Super UserJanuary 10, 2022
Isaac Newton apocryphally discovered his second law – the one about gravity – after an apple fell on his head.…
Super UserJanuary 10, 2022
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment - ROCKVILLE, Md.--(BUSINESS WIRE)--Hibiscus BioVentures,…
Super UserJanuary 10, 2022
The U.S. Economic Development Administration announced last month the winners of $500,000 planning grants to 60 jurisdictions across the country…
Super UserJanuary 7, 2022